Key facts
- This page summarizes Robert Carey's Form 4 filing for Beyond Air, Inc. (XAIR).
- 16 reported transactions and 16 derivative rows are listed below.
- Accepted by SEC: 07 Nov 2025, 16:05.
Robert Carey - 04 Nov 2025 Form 4 Insider Report for Beyond Air, Inc. (XAIR)
- Reporting relationship
- Director
- Issuer ticker
- XAIR
- Reported as of
- 04 Nov 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Nov 2025, 16:05:31 UTC
- Prior SEC filing
- 16 Jun 2025
- Next SEC filing
- 07 Nov 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert F. Carey
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Carey filed Form 4 for Beyond Air, Inc. (XAIR) on 07 Nov 2025.
Change
- Previous filing in this sequence was filed on 16 Jun 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001602064
Primary reporting owner
Carey Robert
- Relationship
- Director
- Address
- C/O BEYOND AIR, INC., 900 STEWART AVENUE, SUITE 301, GARDEN CITY
- Signature
- /s/ Robert F. Carey
- Signature date
- 07 Nov 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
XAIR
transaction
Derivative
Stock Options (Right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -4,500
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 04 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,500
- Exercise price
- $10.80
- Footnotes
- F1, F2
XAIR
transaction
Derivative
Stock Options (Right to buy)
Award
- Transaction value
- Shares
- +4,500
- Change %
- Price
- Shares after
- 4,500
- Date
- 04 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,500
- Exercise price
- $1.95
- Footnotes
- F1, F2
XAIR
transaction
Derivative
Stock Options (Right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -2,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 04 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,000
- Exercise price
- $10.80
- Footnotes
- F1, F2
XAIR
transaction
Derivative
Stock Options (Right to buy)
Award
- Transaction value
- Shares
- +2,000
- Change %
- Price
- Shares after
- 2,000
- Date
- 04 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,000
- Exercise price
- $1.95
- Footnotes
- F1, F2
XAIR
transaction
Derivative
Stock Options (Right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -1,500
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 04 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,500
- Exercise price
- $10.80
- Footnotes
- F1, F2
XAIR
transaction
Derivative
Stock Options (Right to buy)
Award
- Transaction value
- Shares
- +1,500
- Change %
- Price
- Shares after
- 1,500
- Date
- 04 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,500
- Exercise price
- $1.95
- Footnotes
- F1, F2
XAIR
transaction
Derivative
Stock Options (Right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -1,250
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 04 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,250
- Exercise price
- $10.80
- Footnotes
- F1, F2
XAIR
transaction
Derivative
Stock Options (Right to buy)
Award
- Transaction value
- Shares
- +1,250
- Change %
- Price
- Shares after
- 1,250
- Date
- 04 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,250
- Exercise price
- $1.95
- Footnotes
- F1, F2
XAIR
transaction
Derivative
Stock Options (Right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -1,250
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 04 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,250
- Exercise price
- $10.80
- Footnotes
- F1, F2
XAIR
transaction
Derivative
Stock Options (Right to buy)
Award
- Transaction value
- Shares
- +1,250
- Change %
- Price
- Shares after
- 1,250
- Date
- 04 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,250
- Exercise price
- $1.95
- Footnotes
- F1, F2
XAIR
transaction
Derivative
Stock Options (Right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -50
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 04 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50
- Exercise price
- $10.80
- Footnotes
- F1, F2
XAIR
transaction
Derivative
Stock Options (Right to buy)
Award
- Transaction value
- Shares
- +50
- Change %
- Price
- Shares after
- 50
- Date
- 04 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50
- Exercise price
- $1.95
- Footnotes
- F1, F2
XAIR
transaction
Derivative
Stock Options (Right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -1,250
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 04 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,250
- Exercise price
- $10.80
- Footnotes
- F1, F2
XAIR
transaction
Derivative
Stock Options (Right to buy)
Award
- Transaction value
- Shares
- +1,250
- Change %
- Price
- Shares after
- 1,250
- Date
- 04 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,250
- Exercise price
- $1.95
- Footnotes
- F1, F2
XAIR
transaction
Derivative
Stock Options (Right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -10,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 04 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $5.89
- Footnotes
- F1, F2
XAIR
transaction
Derivative
Stock Options (Right to buy)
Award
- Transaction value
- Shares
- +10,000
- Change %
- Price
- Shares after
- 10,000
- Date
- 04 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $1.95
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged.
Footnote F2
This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.